US 7612044
Melanoma antigens and their use in diagnostic and therapeutic methods
granted A61KA61K2039/5256A61K2039/53
Quick answer
US patent 7612044 (Melanoma antigens and their use in diagnostic and therapeutic methods) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/5256, A61K2039/53, A61K2239/31, A61K2239/38